Ligase Enzymes Market Size, Share, and Trends 2026 to 2035

Ligase Enzymes Market (By Type: T4 DNA Ligase, Taq DNA Ligase, Ligase Chain Reaction Enzymes, RNA Ligase, Thermostable ligase; By Source: Bacteria, Fungi, Plant, Animal, Synthetic; By Application: Molecular Biology, Genetic Engineering, Pharmaceuticals, Diagnostics, Agriculture; By End-User: Research Laboratories, Biotechnology Companies, Pharmaceutical Companies, Academic Institution) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2026 to 2035

Last Updated : 04 Mar 2026  |  Report Code : 7968  |  Category : Healthcare   |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Ligase Enzymes Market 

5.1. COVID-19 Landscape: Ligase Enzymes Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Ligase Enzymes Market, By Type

8.1. Ligase Enzymes Market Revenue and Volume Forecast, by Type

8.1.1. T4 DNA Ligase

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Taq DNA Ligase

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Ligase Chain Reaction Enzymes

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. RNA Ligase

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Thermostable ligase

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global Ligase Enzymes Market, By Source

9.1. Ligase Enzymes Market Revenue and Volume Forecast, by Source

9.1.1. Bacteria

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Fungi

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Plant

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Animal

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Synthetic

9.1.5.1. Market Revenue and Volume Forecast

Chapter 10. Global Ligase Enzymes Market, By Application

10.1. Ligase Enzymes Market Revenue and Volume Forecast, by Application

10.1.1. Molecular Biology

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Genetic Engineering

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Pharmaceuticals

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Diagnostics

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Agriculture

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Ligase Enzymes Market, By End-User

11.1. Ligase Enzymes Market Revenue and Volume Forecast, by End-User

11.1.1. Research Laboratories

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Biotechnology Companies

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Pharmaceutical Companies

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Academic Institution

11.1.4.1. Market Revenue and Volume Forecast

Chapter 12. Global Ligase Enzymes Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Type

12.1.2. Market Revenue and Volume Forecast, by Source

12.1.3. Market Revenue and Volume Forecast, by Application

12.1.4. Market Revenue and Volume Forecast, by End-User

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Type

12.1.5.2. Market Revenue and Volume Forecast, by Source

12.1.5.3. Market Revenue and Volume Forecast, by Application

12.1.5.4. Market Revenue and Volume Forecast, by End-User

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Type

12.1.6.2. Market Revenue and Volume Forecast, by Source

12.1.6.3. Market Revenue and Volume Forecast, by Application

12.1.6.4. Market Revenue and Volume Forecast, by End-User

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Type

12.2.2. Market Revenue and Volume Forecast, by Source

12.2.3. Market Revenue and Volume Forecast, by Application

12.2.4. Market Revenue and Volume Forecast, by End-User

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Type

12.2.5.2. Market Revenue and Volume Forecast, by Source

12.2.5.3. Market Revenue and Volume Forecast, by Application

12.2.5.4. Market Revenue and Volume Forecast, by End-User

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Type

12.2.6.2. Market Revenue and Volume Forecast, by Source

12.2.6.3. Market Revenue and Volume Forecast, by Application

12.2.6.4. Market Revenue and Volume Forecast, by End-User

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Type

12.2.7.2. Market Revenue and Volume Forecast, by Source

12.2.7.3. Market Revenue and Volume Forecast, by Application

12.2.7.4. Market Revenue and Volume Forecast, by End-User

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Type

12.2.8.2. Market Revenue and Volume Forecast, by Source

12.2.8.3. Market Revenue and Volume Forecast, by Application

12.2.8.4. Market Revenue and Volume Forecast, by End-User

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Type

12.3.2. Market Revenue and Volume Forecast, by Source

12.3.3. Market Revenue and Volume Forecast, by Application

12.3.4. Market Revenue and Volume Forecast, by End-User

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Type

12.3.5.2. Market Revenue and Volume Forecast, by Source

12.3.5.3. Market Revenue and Volume Forecast, by Application

12.3.5.4. Market Revenue and Volume Forecast, by End-User

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Type

12.3.6.2. Market Revenue and Volume Forecast, by Source

12.3.6.3. Market Revenue and Volume Forecast, by Application

12.3.6.4. Market Revenue and Volume Forecast, by End-User

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Type

12.3.7.2. Market Revenue and Volume Forecast, by Source

12.3.7.3. Market Revenue and Volume Forecast, by Application

12.3.7.4. Market Revenue and Volume Forecast, by End-User

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Type

12.3.8.2. Market Revenue and Volume Forecast, by Source

12.3.8.3. Market Revenue and Volume Forecast, by Application

12.3.8.4. Market Revenue and Volume Forecast, by End-User

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Type

12.4.2. Market Revenue and Volume Forecast, by Source

12.4.3. Market Revenue and Volume Forecast, by Application

12.4.4. Market Revenue and Volume Forecast, by End-User

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Type

12.4.5.2. Market Revenue and Volume Forecast, by Source

12.4.5.3. Market Revenue and Volume Forecast, by Application

12.4.5.4. Market Revenue and Volume Forecast, by End-User

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Type

12.4.6.2. Market Revenue and Volume Forecast, by Source

12.4.6.3. Market Revenue and Volume Forecast, by Application

12.4.6.4. Market Revenue and Volume Forecast, by End-User

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Type

12.4.7.2. Market Revenue and Volume Forecast, by Source

12.4.7.3. Market Revenue and Volume Forecast, by Application

12.4.7.4. Market Revenue and Volume Forecast, by End-User

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Type

12.4.8.2. Market Revenue and Volume Forecast, by Source

12.4.8.3. Market Revenue and Volume Forecast, by Application

12.4.8.4. Market Revenue and Volume Forecast, by End-User

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Type

12.5.2. Market Revenue and Volume Forecast, by Source

12.5.3. Market Revenue and Volume Forecast, by Application

12.5.4. Market Revenue and Volume Forecast, by End-User

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Type

12.5.5.2. Market Revenue and Volume Forecast, by Source

12.5.5.3. Market Revenue and Volume Forecast, by Application

12.5.5.4. Market Revenue and Volume Forecast, by End-User

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Type

12.5.6.2. Market Revenue and Volume Forecast, by Source

12.5.6.3. Market Revenue and Volume Forecast, by Application

12.5.6.4. Market Revenue and Volume Forecast, by End-User

Chapter 13. Company Profiles

13.1. GenScript

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Enzo Life Sciences

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Takara Bio

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. QIAGEN N.V.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Becton

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Merck

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Oxford Nanopore Technologies

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Thermo Fisher Scientific

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Promega Corporation

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. New England Biolabs

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The ligase enzymes market size is expected to increase from USD 1.31 billion in 2025 to USD 2.57 billion by 2035.

Answer : The ligase enzymes market is expected to grow at a compound annual growth rate (CAGR) of around 7.02% from 2026 to 2035.

Answer : The major players in the ligase enzymes market include Thermo Fisher Scientific, Oxford Nanopore Technologies, Merck, Promega Corporation, New England Biolabs, Promega, Illumina, Agilent Technologies, Zymo Research, F. Hoffmann-la Roche, GenScript, Enzo Life Sciences, Takara Bio, QIAGEN N.V., Becton, BioVision, Dickinson, and Genetix Biotech

Answer : The driving factors of the ligase enzymes market are increasing need for genetic research and diagnostic applications, including genetic engineering, DNA repair, and recombinant DNA technology, which are indispensable for the development of biotechnological research and pharmaceutical development on a global scale

Answer : North America region will lead the global ligase enzymes market during the forecast period 2026 to 2035.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client